Medicine Matters - a podcast from Medicines UK

Episode 10 - Dominic Wake, the head of corporate affairs, northern cluster at Sandoz, and a Medicines UK member speaks to Dr Jacoline Bouvy, the Deputy Director for Medicines Evaluation at NICE. They discuss NICE’s whole life cycle approach, as well as the agency’s strategic plans to create greater patient access to clinically proven and cost-effective medicines.

In this latest episode of the Medicines Matters podcast bought to you by Medicines UK, Jeremy Durrant talks to his colleagues Paul Fleming and Robert Russell-Pavier about Project Revive - a collaborative programme with NHS England and the MHRA aimed at stimulating supply of strategically important NHS medicines.

Episode 8 - Jeremy Durrant, director of communications and external engagement, at Medicines UK speaks to Alwyn Fortune Policy and Engagement Lead - Wales, from the Royal College of Pharmacy (previously the Royal Pharmaceutical Society), alongside Paul Fleming, technical director at Medicines UK. They discuss the topic of shortages following publication of the updated Royal College of Pharmacy’s Medicines shortages: solutions for empty shelves — one year on report.

Jeremy Durrant, director of communications and external engagement, at Medicines UK speaks to Michelle Riddalls, chief executive of the PAGB, the branded over-the-counter healthcare association, alongside Paul Fleming, technical director at Medicines UK. They discuss the topic of reclassification and its potential to transform how, and where, patients access the medicines they need in the future. Medicines UK and PAGB will be holding a webinar on this topic on April 22nd and to find out how to join, email info@medicinesuk.com

In this latest episode of our Medicine Matters podcast, Jeremy Durrant, director of communications and external engagement, at Medicines UK, speaks to Charles Joynson, manging director and co-founder of Wave Data, a unique and independent pharmaceutical pricing data company. They look at pricing trends over the past 12 months and discuss what to expect in 2026. To find out more about Wave Data - visit https://www.wavedata.co.uk/

In this latest episode of the Medicine Matters podcast from Medicines UK, Adele Paterson, chief executive of International Health Partners (IHP) talks to Jeremy Durrant about the role of the NGO in distributing essential medicines to where they are needed most in the world.

Lily Smart, Head of Commercial Intiatives at Sandoz, a Medicines UK member company, speaks to Harry McQuillan, chair of Numark and former chief executive of Community Pharmacy Scotland on the changing landscape in pharmacy, how to make a success of the NHS 10-year plan and the future trends within the sector.

In this latest episode of the Medicine Matters podcast brought to you by Medicines UK, we explore loss of exclusivity data and why its important to the NHS. Jeremy Durrant, director of communications and external engagement at Medicines UK talks to his colleague Robert Russell-Pavier, Director of Economics and Public Affairs on forthcoming patent expirations and what they will mean for savings and crucially patient access.

In the second episode of the British Generic Manufacturers Association's podcast series, chair Diane DiGangi-Trench speaks to Clara Carter, who is heading up the BGMA's new women's network.

The BGMA is the trade body for manufacturers of off-patent generic and biosimilar medicines which fulfil four out of five NHS prescriptions. In our podcast we speak to Government partners and stakeholders about the key issues for our sector highlighting challenges and opportunities.